Taiwan In Vitro Diagnostics Market Outlook to 2016 now available at ReportsandReports
08/06/2010

GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Taiwan In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology.

Online PR News – 06-August-2010 – – Dallas, TX: ReportsandReports announce it Taiwan In Vitro Diagnostics Market Outlook to 2016 Market Research Report in its Store.

Browse complete Report at http://www.reportsandreports.com/market-reports/taiwan-in-vitro-diagnostics-market-outlook-to-2016/
GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Taiwan In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
• Market size and company share data for In Vitro Diagnostics (IVD) market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the Taiwan In Vitro Diagnostics (IVD) market.
• Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Taiwan In Vitro Diagnostics (IVD) competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What is This Report About? 15
3 In Vitro Diagnostics In Taiwan 16
3.1 In Vitro Diagnostics, Market Segmentation 16
3.2 In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 17
3.3 In Vitro Diagnostics Market, Taiwan, Revenue Mix ($m), 2009 19
3.4 In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20
3.5 In Vitro Diagnostics, Taiwan, Company Share (2008-2009) 26
4 Clinical Chemistry In Taiwan 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, Taiwan, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 39
4.5 Clinical Chemistry Distribution Share (2008-2009) 43
4.6 Clinical Chemistry, Taiwan, Company Share (2008-2009) 44
5 Genetic Testing In Taiwan 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, Taiwan, Revenue Mix ($m), 2009 47
5.3 Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48
5.4 Genetic Testing Overall Revenue (2002-2016) 49
5.5 Genetic Testing Distribution Share (2008-2009) 53
5.6 Genetic Testing, Taiwan, Company Share (2008-2009) 54
6 Haematology In Taiwan 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, Taiwan, Revenue Mix ($m), 2009 56
6.3 Haematology Market, Taiwan, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 65
6.4.3 Haemostasis Revenue (2002-2016) 67
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 71
6.4.5 Haematology Cell Counters Revenue (2002-2016) 74
6.5 Haematology Distribution Share (2008-2009) 76
6.6 Haematology, Taiwan, Company Share (2008-2009) 77
7 Histology And Cytology In Taiwan 79
7.1 Histology and Cytology, Market Segmentation 79
7.2 Histology and Cytology Market, Taiwan, Revenue Mix ($m), 2009 80
7.3 Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81
7.4 Histology and Cytology Overall Revenue (2002-2016) 82
7.4.1 Histology Revenue (2002-2016) 85
7.5 Histology And Cytology Distribution Share (2008-2009) 88
7.6 Histology And Cytology, Taiwan, Company Share (2008-2009) 89
8 Immuno Chemistry In Taiwan 90
8.1 Immuno Chemistry, Market Segmentation 90
8.2 Immuno Chemistry Market, Taiwan, Revenue Mix ($m), 2009 91
8.3 Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92
8.4 Immuno Chemistry Overall Revenue (2002-2016) 93
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 97
8.4.2 Drug Related Testing Revenue (2002-2016) 101
8.4.3 Endocrinology Tests Revenue (2002-2016) 103
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 107
8.5 Immuno Chemistry Distribution Share (2008-2009) 111
8.6 Immuno Chemistry, Taiwan, Company Share (2008-2009) 112
9 Infectious Immunology In Taiwan 114
9.1 Infectious Immunology, Market Segmentation 114
9.2 Infectious Immunology Market, Taiwan, Revenue Mix ($m), 2009 115
9.3 Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116
9.4 Infectious Immunology Overall Revenue (2002-2016) 117
9.5 Infectious Immunology Distribution Share (2008-2009) 121
9.6 Infectious Immunology, Taiwan, Company Share (2008-2009) 122
10 Microbiology Culture In Taiwan 124
10.1 Microbiology Culture, Market Segmentation 124
10.2 Microbiology Culture Market, Taiwan, Revenue Mix ($m), 2009 125
10.3 Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126
10.4 Microbiology Culture Overall Revenue (2002-2016) 127
10.4.1 Microbiology Analyzers Revenue (2002-2016) 131
10.5 Microbiology Culture Distribution Share (2008-2009) 133
10.6 Microbiology Culture, Taiwan, Company Share (2008-2009) 134
11 Overview of Key Companies in Taiwan In Vitro Diagnostics Market 135
11.1 F. Hoffmann-La Roche Ltd. 135
11.1.1 Company Overview 135
11.1.2 Share in the Taiwan In Vitro Diagnostics Market 135
11.2 Siemens Healthcare 136
11.2.1 Company Overview 136
11.2.2 Share in the Taiwan In Vitro Diagnostics Market 136
11.3 Beckman Coulter, Inc. 137
11.3.1 Company Overview 137
11.3.2 Share in the Taiwan In Vitro Diagnostics Market 137
11.4 Ortho-Clinical Diagnostics Inc. 138
11.4.1 Company Overview 138
11.4.2 Share in the Taiwan In Vitro Diagnostics Market 138
11.5 Abbott Laboratories 139
11.5.1 Company Overview 139
11.5.2 Share in the Taiwan In Vitro Diagnostics Market 139
11.6 bioMerieux S.A. 140
11.6.1 Company Overview 140
11.6.2 Share in the Taiwan In Vitro Diagnostics Market 140
11.7 Inverness Medical Innovations, Inc. 141
11.7.1 Company Overview 141
11.8 Becton, Dickinson and Company 141
11.8.1 Company Overview 141
11.9 Bio-Rad Laboratories, Inc. 142
11.9.1 Company Overview 142
11.10 Hologic, Inc. 142
11.10.1 Company Overview 142
11.11 OLYMPUS CORPORATION 143
11.11.1 Company Overview 143
11.12 Mindray Medical International Limited 143
11.12.1 Company Overview 143
11.13 Sysmex Corporation 144
11.13.1 Company Overview 144
11.14 Ventana Medical Systems, Inc. 144
11.14.1 Company Overview 144
11.15 DiaSorin S.p.A 144
11.15.1 Company Overview 144
11.16 Qiagen N.V. 145
11.16.1 Company Overview 145
11.17 Gen-Probe Incorporated 145
11.17.1 Company Overview 145
11.18 Phadia AB 145
11.18.1 Company Overview 145
11.19 BioCare Corporation 146
11.19.1 Company Overview 146
11.20 AsiaGen Corporation 146
11.20.1 Company Overview 146
11.21 Oncoprobe Biotech Inc. 146
11.21.1 Company Overview 146
11.22 Exploit Technologies Pte Ltd 147
11.22.1 Company Overview 147
11.23 Apex Biotechnology Corp. 147
11.23.1 Company Overview 147
11.24 Health & Life Co., Ltd. 147
11.24.1 Company Overview 147
11.25 Eumed Biotechnology Co., Ltd. 148
11.25.1 Company Overview 148
11.26 Vita Genomics, Inc. 148
11.26.1 Company Overview 148
11.27 Formosa Biomedical Technology Corp. 148
11.27.1 Company Overview 148
12 In Vitro Diagnostics Market Pipeline Products 149
12.1 Clinical Chemisty Market Pipeline Products 149
12.2 Immuno Chemistry Market Pipeline Products 151
12.3 Haematology Market Pipeline Products 152
12.4 Infectious Immunology Market Pipeline Products 153
12.5 Microbiology Culture Market Pipeline Products 155
12.6 Histology and Cytology Market Pipeline Products 156
12.7 Genetic Testing Market Pipeline Products 157
13 Financial Deals Landscape 159
13.1 Partnerships 159
13.1.1 QIAGEN Enters Into Distribution Agreement With Celera 159
13.1.2 Sequenom Enters Into Licensing Agreement With Optherion 160
13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 161
13.1.4 TriLink BioTechnologies Enters Into Distribution Agreement With Nacalai USA 162
13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 163
13.1.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 164
13.1.7 DxS Signs Cross-Licensing Agreement With Epigenomics 165
14 Appendix 166
14.1 Definitions of Markets Covered in the Report 167
14.1.1 In Vitro Diagnostics 167
14.2 Research Methodology 174
14.3 Secondary Research 175
14.4 Primary Research 175
14.5 Models 176
14.6 Forecasts 176
14.7 Expert Panels 176
14.8 GlobalData Consulting 176
14.9 Currency Conversion 177
14.10 Contact Us 177
14.11 Disclaimer 177

1.1 List of Tables

Table 1: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 18
Table 2: In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20
Table 3: In Vitro Diagnostics, Taiwan, Cross-Category Analysis, 2002-2016 21
Table 4: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Historic, 2002-2009 23
Table 5: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Forecast, 2009-2016 25
Table 6: In Vitro Diagnostics, Taiwan, Company Share by Revenue ($m), 2008-2009 27
Table 7: Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30
Table 8: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 32
Table 9: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 34
Table 10: Clinical Chemisty Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 36
Table 11: Clinical Chemisty Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 38
Table 12: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Table 13: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42
Table 14: Clinical Chemistry, Taiwan, Distribution Share by Revenue ($m), 2008-2009 43
Table 15: Clinical Chemistry, Taiwan, Company Share by Revenue ($m), 2008-2009 45
Table 16: Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48
Table 17: Genetic Testing, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 50
Table 18: Genetic Testing, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 52
Table 19: Genetic Testing, Taiwan, Distribution Share by Revenue ($m), 2008-2009 53
Table 20: Genetic Testing, Taiwan, Company Share by Revenue ($m), 2008-2009 54
Table 21: Haematology Market, Taiwan, Category Contribution (%), 2009 57
Table 22: Haematology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 59
Table 23: Haematology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 61
Table 24: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63
Table 25: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Table 26: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 65
Table 27: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 66
Table 28: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 68
Table 29: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 70
Table 30: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71
Table 31: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73
Table 32: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74
Table 33: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 75
Table 34: Haematology, Taiwan, Distribution Share by Revenue ($m), 2008-2009 76
Table 35: Haematology, Taiwan, Company Share by Revenue ($m), 2008-2009 78
Table 36: Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81
Table 37: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 83
Table 38: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 84
Table 39: Histology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 86
Table 40: Histology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 87
Table 41: Histology And Cytology, Taiwan, Distribution Share by Revenue ($m), 2008-2009 88
Table 42: Histology And Cytology, Taiwan, Company Share by Revenue ($m), 2008-2009 89
Table 43: Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92
Table 44: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 94
Table 45: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 96
Table 46: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 98
Table 47: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 100
Table 48: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 101
Table 49: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 102
Table 50: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 104
Table 51: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 106
Table 52: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 108
Table 53: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 110
Table 54: Immuno Chemistry, Taiwan, Distribution Share by Revenue ($m), 2008-2009 111
Table 55: Immuno Chemistry, Taiwan, Company Share by Revenue ($m), 2008-2009 113
Table 56: Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116
Table 57: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 118
Table 58: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 120
Table 59: Infectious Immunology, Taiwan, Distribution Share by Revenue ($m), 2008-2009 121
Table 60: Infectious Immunology, Taiwan, Company Share by Revenue ($m), 2008-2009 123
Table 61: Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126
Table 62: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 128
Table 63: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 130
Table 64: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 131
Table 65: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 132
Table 66: Microbiology Culture, Taiwan, Distribution Share by Revenue ($m), 2008-2009 133
Table 67: Microbiology Culture, Taiwan, Company Share by Revenue ($m), 2008-2009 134
Table 68: Clinical Chemisty Market Pipeline Products 149
Table 69: Immuno Chemistry Market Pipeline Products 151
Table 70: Haematology Market Pipeline Products 152
Table 71: Infectious Immunology Market Pipeline Products 153
Table 72: Microbiology Culture Market Pipeline Products 155
Table 73: Histology and Cytology Market Pipeline Products 156
Table 74: Genetic Testing Market Pipeline Products 157
Table 75: QIAGEN Enters Into Distribution Agreement With Celera 159
Table 76: Sequenom Enters Into Licensing Agreement With Optherion 160
Table 77: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 161
Table 78: TriLink BioTechnologies Enters Into Distribution Agreement With Nacalai USA 162
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 163
Table 80: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 164
Table 81: DxS Signs Cross-Licensing Agreement With Epigenomics 165
Table 82: USD to Local Currency, Taiwan, Average Actual Rate 2002-2009 177

1.2 List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 16
Figure 2: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 17
Figure 3: In Vitro Diagnostics Market, Taiwan, Revenue Mix ($m), 2009 19
Figure 4: In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20
Figure 5: In Vitro Diagnostics, Taiwan, Cross-Category Analysis, 2002-2016 21
Figure 6: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Historic, 2002-2009 22
Figure 7: In Vitro Diagnostics, Taiwan, Overall Revenue ($m), Forecast, 2009-2016 24
Figure 8: In Vitro Diagnostics, Taiwan, Company Share (%), 2009 26
Figure 9: Clinical Chemistry, Market Segmentation 28
Figure 10: Clinical Chemistry Market, Taiwan, Revenue Mix ($m), 2009 29
Figure 11: Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30
Figure 12: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 31
Figure 13: Clinical Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 33
Figure 14: Clinical Chemisty Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35
Figure 15: Clinical Chemisty Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37
Figure 16: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Figure 17: Urine Analysis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 18: Clinical Chemistry, Taiwan, Company Share (%), 2009 44
Figure 19: Genetic Testing, Market Segmentation 46
Figure 20: Genetic Testing Market, Taiwan, Revenue Mix ($m), 2009 47
Figure 21: Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48
Figure 22: Genetic Testing, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 49
Figure 23: Genetic Testing, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 51
Figure 24: Genetic Testing, Taiwan, Company Share (%), 2009 54
Figure 25: Haematology, Market Segmentation 55
Figure 26: Haematology Market, Taiwan, Revenue Mix ($m), 2009 56
Figure 27: Haematology Market, Taiwan, Category Contribution (%), 2009 57
Figure 28: Haematology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 58
Figure 29: Haematology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 60
Figure 30: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Figure 31: Haematology Reagents, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Figure 32: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 65
Figure 33: Immunohaematology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 66
Figure 34: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67
Figure 35: Haemostasis, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69
Figure 36: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71
Figure 37: Haematology Rapid Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Figure 38: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74
Figure 39: Haematology Cell Counters, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 75
Figure 40: Haematology, Taiwan, Company Share (%), 2009 77
Figure 41: Histology and Cytology, Market Segmentation 79
Figure 42: Histology and Cytology Market, Taiwan, Revenue Mix ($m), 2009 80
Figure 43: Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81
Figure 44: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 82
Figure 45: Histology And Cytology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 84
Figure 46: Histology, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 85
Figure 47: Histology, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 87
Figure 48: Histology And Cytology, Taiwan, Company Share (%), 2009 89
Figure 49: Immuno Chemistry, Market Segmentation 90
Figure 50: Immuno Chemistry Market, Taiwan, Revenue Mix ($m), 2009 91
Figure 51: Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92
Figure 52: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 93
Figure 53: Immuno Chemistry, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 95
Figure 54: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 97
Figure 55: Disease Specific Immunochemistry, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 99
Figure 56: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 101
Figure 57: Drug Related Testing, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 102
Figure 58: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 103
Figure 59: Endocrinology Tests, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 105
Figure 60: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107
Figure 61: Immunochemistry Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 109
Figure 62: Immuno Chemistry, Taiwan, Company Share (%), 2009 112
Figure 63: Infectious Immunology, Market Segmentation 114
Figure 64: Infectious Immunology Market, Taiwan, Revenue Mix ($m), 2009 115
Figure 65: Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116
Figure 66: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 117
Figure 67: Infectious Immunology, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 119
Figure 68: Infectious Immunology, Taiwan, Company Share (%), 2009 122
Figure 69: Microbiology Culture, Market Segmentation 124
Figure 70: Microbiology Culture Market, Taiwan, Revenue Mix ($m), 2009 125
Figure 71: Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126
Figure 72: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 127
Figure 73: Microbiology Culture, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 129
Figure 74: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 131
Figure 75: Microbiology Analyzers, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 132
Figure 76: Microbiology Culture, Taiwan, Company Share (%), 2009 134
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 135
Figure 78: Siemens Healthcare, Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 136
Figure 79: Beckman Coulter, Inc., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 137
Figure 80: Ortho-Clinical Diagnostics Inc., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 138
Figure 81: Abbott Laboratories, Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 139
Figure 82: bioMerieux S.A., Company Share (%),Taiwan In Vitro Diagnostics Market, 2009 140
Figure 83: GlobalData Methodology 174
Browse all Medical Devices Market Research Reports
Browse all GlobalData Market Research Reports
Browse all Newly Published Market Research Reports

Related Reports:
Taiwan Diagnostic Imaging Market Outlook to 2016
Japan In Vitro Diagnostics Market Outlook to 2016
India In Vitro Diagnostics Market Outlook to 2016

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/